This study systematically explored the expression pattern and clinical significance of SPOCK1 (SPARC/osteonectin, CWCV and Kazal-like domains proteoglycan 1) across multiple cancer types, with a particular focus on its role in breast cancer. Here, SPOCK1 is linked to breast carcinoma.